Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 22;S2210-7401(20)30104-2.
doi: 10.1016/j.clinre.2020.04.001. Online ahead of print.

Suggestions for the Care of Patients With Liver Disease During the Coronavirus 2019 Pandemic

Affiliations
Free PMC article
Review

Suggestions for the Care of Patients With Liver Disease During the Coronavirus 2019 Pandemic

Nathalie Ganne-Carrié et al. Clin Res Hepatol Gastroenterol. .
Free PMC article

Abstract

This document, written by the French Association for the Study of the Liver (AFEF) board, aims to provide information to physicians involved in the care of patients with liver disease during the Coronavirus disease (COVID-19) epidemic. These are not based on a systematic review of the literature and a rigorous evaluation using the GRADE method. These are recommendations based on feedback from China available in the form of original articles or letters - for which the scientific evidence is often modest - and the rules put forward by American (1) and European (Boettler et al, 2020) hepatology societies, the French National Digestive Cancer Thesaurus (Di Fiore et al., 2020) and the Francophone Transplantation Society (4). These suggestions require adjustment according to the geographical particularities of the epidemic, available standard procedures and access to local resources. This document will be updated as regularly as possible according to the evolution of our knowledge and characteristics on the epidemic.

Keywords: COVID-19; Cholangiocytes; Chronic liver disease; SARS-CoV-2.

Similar articles

See all similar articles

References

    1. Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic. https://www.aasld.org/sites/default/files/2020-03/AASLD-COVID19-ClinicalInsights-3.23.2020-FINAL-v2.pdf.
    1. Boettler T., Newsome P.N., Mondelli M., Maticic M., Scudeller L., Cornberg M. EASL-ESCMID Considerations for the care of patients with liver disease during the COVID-19 pandemic. J Hepatol Reports. 2020 [In Press]
    1. Di Fiore F., Bouché O., Lepage C., Sefrioui D., Gangloff A., Schwartz L. Propositions of alternatives in digestive cancers management during the COVID-19 epidemic period: A French intergroup clinical point of view (TNCD) Dig Liver Dis. 2020 [sous presse], https://www.snfge.org/content/21-prise-en-charge-des-cancers-digestifs-en-fonction-de-la-situation-epidemique-covid-19.
    1. https://www.transplantation-francophone.org/images/public/COVID19_et_transplantees_d_organes_solides_Guide_pratiquev1_SFT_SFNDT_SP.pdf
    1. Zhang C., Shi L., Wang F.S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020 doi: 10.1016/S2468-1253(20)30057-1. [pii: S2468-1253(20)30057-1 PMID: 32145190] - DOI
Feedback